BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age

BACKGROUND: Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and specifically against infection with the omicron variant among children 5 to 11 years of age. METHODS: Using data from the largest health care organization...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Stavi, Chandra J., Magen, Ori, Barda, Noam, Yaron, Shlomit, Peretz, Alon, Netzer, Doron, Giaquinto, Carlo, Judd, Ali, Leibovici, Leonard, Hernán, Miguel A., Lipsitch, Marc, Reis, Ben Y., Balicer, Ran D., Dagan, Noa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258754/
https://www.ncbi.nlm.nih.gov/pubmed/35767475
http://dx.doi.org/10.1056/NEJMoa2205011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258754/
https://www.ncbi.nlm.nih.gov/pubmed/35767475
http://dx.doi.org/10.1056/NEJMoa2205011

Ejemplares similares